Charles Silberstein is Chief Financial Officer of Applied Therapeutics Inc.. Currently has a direct ownership of 183,603 shares of APLT, which is worth approximately $152,390. The most recent transaction as insider was on Jan 07, 2022, when has been sold 47,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 184K
0% 3M change
0% 12M change
Total Value Held $152,390

Charles Silberstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 07 2022
BUY
Grant, award, or other acquisition
-
47,900 Added 20.69%
183,603 Common Stock
Dec 14 2021
BUY
Grant, award, or other acquisition
-
47,900 Added 26.09%
135,703 Common Stock
Jun 08 2021
SELL
Open market or private sale
$108,107 $21.42 p/Share
5,047 Reduced 5.44%
87,803 Common Stock
CS

Charles Silberstein

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on APLT

Follow Applied Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLT shares.

Notify only if

Insider Trading

Get notified when an Applied Therapeutics Inc. insider buys or sells APLT shares.

Notify only if

News

Receive news related to Applied Therapeutics Inc.

Track Activities on APLT